Evidence map›Paper›PMID 35216457›Full record

ArticleInternational journal of molecular sciences2022

Pre-Transplant Serum Leptin Levels and Relapse of Acute Myeloid Leukemia after Allogeneic Transplantation.

Mark-Alexander Schwarzbich, Hao Dai, Lambros Kordelas, Dietrich W Beelen, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, Thomas Luft

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mark-Alexander SchwarzbichDepartment of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany.
Hao DaiDepartment of Epidemiology, German Cancer Research Centre (DKFZ), 69120 Heidelberg, Germany.
Lambros KordelasDepartment of Bone Marrow Transplantation, University Hospital, 45122 Essen, Germany.ORCID 0000-0003-3116-473X
Dietrich W BeelenDepartment of Bone Marrow Transplantation, University Hospital, 45122 Essen, Germany.
Aleksandar RadujkovicDepartment of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0002-8543-5016
Carsten Müller-TidowDepartment of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany.
Peter DregerDepartment of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany.
Thomas LuftDepartment of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0002-0387-1640
Heidelberg University · DEEssen University Hospital · DEGerman Cancer Research Center · DE

Funding

B.L.U.T. e.V. (Weingarten) n.a.Deutsche Forschungsgemeinschaft TL820.8-1EU's seventh framework programme 306240Wilhelm Sander Stiftung 2016.077.1
6 · The paper itself

Abstract

Weight loss and metabolic activity influence outcome after allogeneic stem cell transplantation (alloSCT). This study evaluates pre-conditioning Leptin, a peptide hormone involved in metabolism and immune homeostasis, as a prognostic factor for survival, relapse and non-relapse mortality (NRM) following alloSCT. Leptin serum levels prior to conditioning were determined in a cohort of patients transplanted for various hematologic malignancies (

Indexed as

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteHumansLeptinRecurrenceRetrospective StudiesTransplantation, HomologousLeptinacute lymphoblastic leukemiaacute myeloid leukemiaAdiponectinALLallogeneic stem cell transplantationAMLbody mass indexleptinrelapsesurvival

Identifiers

PMID35216457
PMCPMC8879842
OpenAlexW4214754532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.